ArticleThe Journal of clinical investigation2024

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Daqiang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.